Suppr超能文献

胰岛素受体的蛋白酪氨酸激酶活性对于胰岛素介导的受体下调是必需的。

The protein-tyrosine kinase activity of the insulin receptor is necessary for insulin-mediated receptor down-regulation.

作者信息

Russell D S, Gherzi R, Johnson E L, Chou C K, Rosen O M

出版信息

J Biol Chem. 1987 Aug 25;262(24):11833-40.

PMID:2957374
Abstract

We have previously demonstrated that the human insulin receptor, mutated in the ATP-binding domain of the beta-subunit, is kinase-defective and fails to mediate multiple post-receptor actions of insulin in stably transfected Chinese hamster ovary cells (Chou, C.-K., Dull, T. J., Russell, D. S., Gherzi, R., Lebwohl, D., Ullrich, A., and Rosen, O. M. (1987) J. Biol. Chem. 262, 1842-1847). This study addresses the role of protein-tyrosine kinase activity in insulin-mediated receptor down-regulation. Although the mutant insulin proreceptor was properly processed and able to bind insulin like the wild-type human receptor, it differed from the latter in the following respects: 1) it failed to mediate internalization of surface-bound radiolabeled ligand; 2) it did not undergo short- or long-term down-regulation in response to 1 microM insulin; 3) it did not exhibit ligand-promoted receptor turnover; and 4) it was not phosphorylated on either tyrosine or serine residues in response to insulin. Although the cells transfected with the mutant receptor failed to respond to insulin-mediated insulin receptor down-regulation, they were able to down-regulate their insulin-like growth factor I receptors in response to insulin-like growth factor I or high concentrations of insulin and were sensitive to monoclonal antibody-induced down-regulation of their insulin receptors. Antibody-mediated receptor internalization alone, however, was unable to mimic at least one action of insulin, thymidine incorporation into DNA, and did not lead to any phosphorylation of the receptor. It is concluded that either the protein-tyrosine kinase activity of the insulin receptor or its phosphorylation state is essential for ligand-mediated receptor down-regulation.

摘要

我们先前已证明,在β亚基的ATP结合域发生突变的人胰岛素受体具有激酶缺陷,并且在稳定转染的中国仓鼠卵巢细胞中无法介导胰岛素的多种受体后作用(Chou,C.-K.,Dull,T. J.,Russell,D. S.,Gherzi,R.,Lebwohl,D.,Ullrich,A.,和Rosen,O. M.(1987年)《生物化学杂志》262,1842 - 1847)。本研究探讨了蛋白酪氨酸激酶活性在胰岛素介导的受体下调中的作用。尽管突变型胰岛素前受体能够像野生型人受体一样正常加工并结合胰岛素,但它在以下方面与野生型受体不同:1)它无法介导表面结合的放射性标记配体的内化;2)对1 microM胰岛素不发生短期或长期下调;3)不表现出配体促进的受体周转;4)对胰岛素不发生酪氨酸或丝氨酸残基的磷酸化。尽管转染了突变受体的细胞对胰岛素介导的胰岛素受体下调无反应,但它们能够响应胰岛素样生长因子I或高浓度胰岛素下调其胰岛素样生长因子I受体,并且对单克隆抗体诱导的胰岛素受体下调敏感。然而,仅抗体介导的受体内化无法模拟胰岛素的至少一种作用,即胸苷掺入DNA,并且不会导致受体的任何磷酸化。结论是,胰岛素受体的蛋白酪氨酸激酶活性或其磷酸化状态对于配体介导的受体下调至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验